CSL
CSL Ltd
$184.58
▼ -0.12%
Market cap
$88.58B
Turnover
$116,861,305
Last price
$184.58
Day change
-0.12%
Announcements
7
Range, past year
Open 211.0 · Low 90.00 · Now 184.5 · High 275.7
Open CSL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
CSL momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
67/100
Wyckoff phase
Distribution28d
Trend stage
Neutral
1 Day
-0.1%
1 Week
+3.3%
1 Month
+7.6%
1 Year
-11.6%
RSI
65
Avg daily range
2.1%
CSL Ltd scores 67 out of 100 for momentum quality, a reading rated high confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Distribution, where it has been for 28 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads moderate.
What stands out
- Solid momentum quality (MQS 67)
- Trend R² 0.81 — highly linear uptrend
- Above SMA50 for 83 days
- RSI in healthy zone (65)
Points to watch
- MACD histogram turning down
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsCSL announcements
Recent price-sensitive releases.
- 2026-10-05 CSL enters exclusive agreement with Alentis Therapeutics Progress Report
- 2026-08-18 CSL Results Presentation for FY2026 Company Presentation | Preliminary Final Report
- 2026-08-18 CSL FY2026 Results Web Cast | Preliminary Final Report | Dividend Rate
- 2026-08-18 CSL Statutory Accounts for FY2026 Sustainability/Climate Action Report | Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report | Notice of Meeting - Other | Dividend Record Date | Dividend Pay Date | Dividend Rate
- 2026-07-29 CSL Update on Enhanced Plasma Manufacturing Progress Report
- 2026-05-11 Interim CEO 90 Day Review and Financial Update
More Health Care stocks
Most traded in the same sector.